Ulcerative Colitis Clinical Trials in Chicago

Showing 561-580 of 699 trials

Early Indicators of Chronic Rejection in Lung Transplant

NCT00449332

The purpose of this research is to discover the different patterns of cytokine production in patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing rejection. This is an early indicator of chronic rejection in lung transplant recipients. These cytokines can be detected in the bronchoalveolar (lung) and tissue samples of lung transplant recipients.

Chronic Rejection in Lung TransplantCytokine Production in Bos Post Lung Transplant

University of Chicago120 participantsStarted Mar 2006

Chicago, Illinois, United States

TERMINATEDPhase 22.2 miles

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138

Primary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658

Ulcerative Colitis

Sanofi28 participantsStarted Aug 2012

Sun City, Arizona, United States • Mission Hills, California, United States • San Diego, California, United States +38 more locations

Early Indicators of Chronic Rejection in Lung Transplant

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis Trials in Other Cities

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

Partial Wave Spectroscopic Detection of Colon Cancer Risk

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Cervical Preparation Before Dilation and Evacuation

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Developing a COPD Case Finding Methodology for Primary Care

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Other Conditions in Chicago